In vitro studies of aculeacin A, a new antifungal antibiotic.

Aculeacin A is a cyclopeptide-containing long-chain fatty acid, representing a new class of antibiotics. It has a relatively narrow antifungal spectrum in vitro and is highly active against some groups of yeasts. Of 31 strains of Candida ad Torulopsis tested, the majority were susceptible to aculeacin A at 0.31 micrograms per ml or less. On the other hand, the antibiotic was scarcely active or inactive against other yeasts, such as Cryptococcus neoformans, and all filamentous and dimorphic fungi tested. A distinct inoculum effect has been observed in vitro with a number of strains of C. albicans; minimum growth-inhibitory concentrations (MIC) have tended to increase with increased incubation time. MIC values were also increased in the presence of serum. Aculeacin A is fungicidal for growing cells of C. albicans. It was most lethal against sensitive yeasts at 0.08 to 0.31 micrograms per ml, and increases in the concentrations of the drug above this range reduced, rather than increased, its lethal effect.

[1]  E. Schoutens,et al.  Qualitative study of paradoxical zone phenomenon of penicillins against 17 bacterial species of clinical importance. , 1978, Chemotherapy.

[2]  Papulacandins a new family of antibiotics with anti fungal activity part 1 fermentation isolation chemical and biological characterization of papulacandins , 1977 .

[3]  A. Yagi,et al.  STUDIES ON ACULEACIN. II , 1977 .

[4]  T. Saito,et al.  On the mode of action of a new antifungal antibiotic, aculeacin A: inhibition of cell wall synthesis in Saccharomyces cerevisiae. , 1977, The Journal of antibiotics.

[5]  P. Traxler,et al.  Papulacandins, a new family of antibiotics with antifungal activity, I. Fermentation, isolation, chemical and biological characterization of papulacandins A, B, C, D and E. , 1977, The Journal of antibiotics.

[6]  A. Yagi,et al.  STUDIES ON ACULEACIN , 1977 .

[7]  A. Yagi,et al.  Studies on aculeacin. II. Isolation and characterization of aculeacins B, C, D, E, F and G. , 1977, The Journal of antibiotics.

[8]  A. Yagi,et al.  Studies on aculeacin. I. Isolation and characterization of aculeacin A. , 1977, The Journal of antibiotics.

[9]  M. Kuhn,et al.  Struktur des cyclopeptid-antibiotikums sl 7810 (= echinocandinb) , 1976 .

[10]  J. Smith,et al.  Nalidixic Acid: an Antibacterial Paradox , 1975, Antimicrobial Agents and Chemotherapy.

[11]  F. Benz,et al.  Stoffwechselprodukte von Mikroorganismen 143. Mitteilung. Echinocandin B, ein neuartiges Polypeptid‐Antibioticum aus Aspergillus nidulans var. echinulatus: Isolierung und Bausteine , 1974 .

[12]  F. Benz.  Echinocandin B. Ein neuartiges polypeptide-antibiotikum aus Aspergillus nidulans var. echinulatus : Isolierung und bausteine , 1974 .

[13]  R. Holt,et al.  Laboratory assessment of the antimycotic drug clotrimazole , 1972, Journal of clinical pathology.

[14]  J. Waitz,et al.  Chemotherapeutic evaluation of clotrimazole (Bay b 5097, 1 (o-chloro- - -diphenylbenzyl) imidazole). , 1971, Applied microbiology.

[15]  H. Rosenkranz,et al.  Nalidixic Acid and the Metabolism of Escherichia coli , 1970, Journal of bacteriology.

[16]  H. Eagle.  The paradoxically retarded bactericidal activity of penicillin at high concentrations in vitro and in vivo. , 1948, The Journal of clinical investigation.